CDEK
← All organizations

Salarius Pharmaceuticals, LLC

For profitWebsite ↗

Also known as: ARTHUR GRP | Salarius Pharmaceuticals, LLC

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 4, 2018

First marketed drug

Mar 20, 2018

Last known activity

Mar 15, 2024

Acquired by Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. → Salarius Pharmaceuticals, LLC → Flex Pharma, Inc. on Jun 17, 2019

Timeline

2010s

  1. Jun 1, 2010

    Salarius Pharmaceuticals, LLC— Founded

  2. Jan 4, 2019

    Flex Pharma, Inc.— Acquired

  3. Jun 17, 2019

    Flex Pharma, Inc.— Acquired By

  4. Jun 17, 2019

    Flex Pharma, Inc.— Now

  5. Sep 13, 2019

    melphalan— Marketing Organization

Drugs by trial phase (4 distinct, 9 trials)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (5)

Details

Founded
Houston, TX, US Jun 1, 2010
Last known activity
Mar 15, 2024